Envestnet Asset Management
ORKA

Envestnet Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Envestnet Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Sell
18,857
-4,810
-20% -$320K ﹤0.01% 3232
2026
Q1 		$1.16M Buy
23,667
+8,420
+55% +$293K ﹤0.01% 3371
2025
Q4 		$462K Buy
+15,247
New +$425K ﹤0.01% 3754

Other funds holding ORKA

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management's ORKA Position: Q2 2026 in Review

Envestnet Asset Management reduced its Oruka Therapeutics (ORKA) stake by 20% in Q2 2026, selling an estimated $320K and leaving 18,857 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3232.

Envestnet Asset Management first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 49 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Envestnet Asset Management held 18,857 shares of Oruka Therapeutics worth $1.79M as of Q2 2026.
  • Envestnet Asset Management sold 4,810 Oruka Therapeutics shares in Q2 2026, an estimated $320K.
  • Oruka Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3232 holding.
  • Envestnet Asset Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 49 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.